| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lipid transporter activity | 9.39e-04 | 196 | 20 | 3 | GO:0005319 | |
| GeneOntologyBiologicalProcess | oligosaccharide metabolic process | 4.09e-05 | 70 | 20 | 3 | GO:0009311 | |
| HumanPheno | Tortuosity of conjunctival vessels | 2.54e-05 | 4 | 11 | 2 | HP:0000503 | |
| Domain | Sushi | 1.40e-03 | 52 | 20 | 2 | PF00084 | |
| Domain | CCP | 1.51e-03 | 54 | 20 | 2 | SM00032 | |
| Domain | SUSHI | 1.62e-03 | 56 | 20 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.68e-03 | 57 | 20 | 2 | IPR000436 | |
| Domain | PDZ | 9.84e-03 | 141 | 20 | 2 | PF00595 | |
| Domain | PDZ | 1.08e-02 | 148 | 20 | 2 | SM00228 | |
| Domain | - | 1.11e-02 | 150 | 20 | 2 | 2.30.42.10 | |
| Domain | PDZ | 1.12e-02 | 151 | 20 | 2 | PS50106 | |
| Domain | PDZ | 1.14e-02 | 152 | 20 | 2 | IPR001478 | |
| Pathway | REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS | 9.07e-05 | 70 | 18 | 3 | M46438 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.14e-04 | 736 | 18 | 6 | M27287 | |
| Pathway | WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS | 4.54e-04 | 25 | 18 | 2 | M39813 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 4.80e-04 | 299 | 18 | 4 | M41727 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 5.30e-04 | 307 | 18 | 4 | M894 | |
| Pubmed | Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview | 2.93e-04 | 44 | 20 | 2 | 20301507 | |
| Pubmed | 4.58e-04 | 55 | 20 | 2 | 31985874 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.90e-04 | 1201 | 20 | 5 | 35696571 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 4.93e-04 | 1203 | 20 | 5 | 29180619 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.44e-02 | 423 | 20 | 2 | chr12q13 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 9.99e-04 | 57 | 15 | 2 | 1179 | |
| GeneFamily | PDZ domain containing | 6.86e-03 | 152 | 15 | 2 | 1220 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | 1.30e-07 | 567 | 20 | 7 | M16909 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP | 7.17e-05 | 107 | 20 | 3 | M7141 | |
| Coexpression | GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN | 2.49e-04 | 163 | 20 | 3 | M7106 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 3.54e-04 | 457 | 20 | 4 | M1613 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 3.94e-04 | 470 | 20 | 4 | MM1053 | |
| Coexpression | PRC2_EZH2_UP.V1_UP | 4.02e-04 | 192 | 20 | 3 | M2739 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN | 4.15e-04 | 194 | 20 | 3 | M8408 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN | 4.40e-04 | 198 | 20 | 3 | M4959 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DN | 4.40e-04 | 198 | 20 | 3 | M4942 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN | 4.40e-04 | 198 | 20 | 3 | M4498 | |
| Coexpression | GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP | 4.47e-04 | 199 | 20 | 3 | M7817 | |
| Coexpression | GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN | 4.53e-04 | 200 | 20 | 3 | M7230 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 4.53e-04 | 200 | 20 | 3 | M4538 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN | 4.53e-04 | 200 | 20 | 3 | M6630 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN | 4.53e-04 | 200 | 20 | 3 | M6624 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.51e-06 | 193 | 20 | 4 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.57e-06 | 195 | 20 | 4 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.09e-05 | 163 | 20 | 3 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 6.28e-05 | 175 | 20 | 3 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 6.94e-05 | 181 | 20 | 3 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.29e-05 | 184 | 20 | 3 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 7.29e-05 | 184 | 20 | 3 | d97471a4fe17cba6880ccf1a04cc00c741558124 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.41e-05 | 185 | 20 | 3 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.77e-05 | 188 | 20 | 3 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 7.77e-05 | 188 | 20 | 3 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 8.02e-05 | 190 | 20 | 3 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.02e-05 | 190 | 20 | 3 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.02e-05 | 190 | 20 | 3 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 8.02e-05 | 190 | 20 | 3 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.14e-05 | 191 | 20 | 3 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.14e-05 | 191 | 20 | 3 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | 450baeb5c3df7a9445472530002ce38f177a333c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.27e-05 | 192 | 20 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 8.27e-05 | 192 | 20 | 3 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.40e-05 | 193 | 20 | 3 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-05 | 193 | 20 | 3 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-05 | 193 | 20 | 3 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-05 | 193 | 20 | 3 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.53e-05 | 194 | 20 | 3 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.66e-05 | 195 | 20 | 3 | 63e132fd6e4318299dd47bbe8ed3bf120efe46dd | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.66e-05 | 195 | 20 | 3 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-05 | 196 | 20 | 3 | d688350aadc622984d612ae6b2fd7c0113a4ec0f | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.06e-05 | 198 | 20 | 3 | 88b4662be9cc933a402c52673fa5e00fa979c0db | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.06e-05 | 198 | 20 | 3 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 198 | 20 | 3 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 198 | 20 | 3 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.06e-05 | 198 | 20 | 3 | 002424b24dacac553e02d0f764a6e8a1e567b9df | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-05 | 199 | 20 | 3 | 527aae1d9d37a50deefc01fc0c064a53673681bd | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.07e-03 | 109 | 20 | 2 | f4b9fe5335cabe48a5fae7ec51bab0d7bdb17321 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.07e-03 | 109 | 20 | 2 | a84a4a3ac19692e5595b9820d49e12ae336f4bbf | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.07e-03 | 109 | 20 | 2 | f007fa3dc92d6c8543585e47ccec218263b3266e | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.07e-03 | 109 | 20 | 2 | f7d7b67f7585f2ae0ac905bcf3980264cf9234b8 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.07e-03 | 109 | 20 | 2 | 8460683529759585bd363d10a16ee13af2bd4e28 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.36e-03 | 123 | 20 | 2 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c10-IFNG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-03 | 126 | 20 | 2 | d19382597ce5c6546731ac1fd33c7dcb7916b2ea | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.57e-03 | 132 | 20 | 2 | 560e836764ed7806fb18282dfebe434d30112a9a | |
| ToppCell | Endothelial-F|World / shred on cell class and cell subclass (v4) | 1.74e-03 | 139 | 20 | 2 | 32d3c5d35e6c4205711c3500d736fd108443e6b4 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 1.84e-03 | 143 | 20 | 2 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.89e-03 | 145 | 20 | 2 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.99e-03 | 149 | 20 | 2 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-8|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.99e-03 | 149 | 20 | 2 | 0c18acfc5f0a9dd25ee5c38f97498b3278e65b42 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 1.99e-03 | 149 | 20 | 2 | 75422e1a22736375e9ef439db0b2a5efa3f653a3 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 1.99e-03 | 149 | 20 | 2 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-03 | 150 | 20 | 2 | 42fd42a0be918a77aca4e0c91f068bdd5a5d9286 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-03 | 150 | 20 | 2 | c2fcdd62ec85cbf9783a525cd7556e16a1e55cd8 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 151 | 20 | 2 | a306e8dac653bc785d805d8d2d94feec3cb01727 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-03 | 152 | 20 | 2 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 2.07e-03 | 152 | 20 | 2 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-03 | 152 | 20 | 2 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-03 | 152 | 20 | 2 | c21e2152b0130485659051d8fb7fb4589d1ec997 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-03 | 152 | 20 | 2 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.10e-03 | 153 | 20 | 2 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 2.15e-03 | 155 | 20 | 2 | 83430a64c2cb5ad29caa3dacba76c28dd204ac40 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 2.21e-03 | 157 | 20 | 2 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | 264b22d0ffc43049161843bb55d2eccbf5fca575 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | 67945d37027be62c880d3072afa7ca7e97c76c20 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|World / disease group, cell group and cell class | 2.21e-03 | 157 | 20 | 2 | 9dcbabb377da7e93ec9f9abf09576a92877a7e02 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.23e-03 | 158 | 20 | 2 | 41aff0a09a7087a67d0ac91028e4895df729289b | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.26e-03 | 159 | 20 | 2 | 999f30c7273ed77b34537621bcfcc7fc30121138 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / disease group, cell group and cell class | 2.26e-03 | 159 | 20 | 2 | 9e2067f0d76769717f7048dab505fadd36bbb83e | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.26e-03 | 159 | 20 | 2 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.29e-03 | 160 | 20 | 2 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-03 | 160 | 20 | 2 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.29e-03 | 160 | 20 | 2 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.29e-03 | 160 | 20 | 2 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 2.32e-03 | 161 | 20 | 2 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | IIF-Lymphocyte-T_NK-NK_CD56bright|IIF / Disease, Lineage and Cell Type | 2.32e-03 | 161 | 20 | 2 | b1bd1074ecba4cf171d748e2f686e9a99c0f0e89 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-03 | 162 | 20 | 2 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-03 | 162 | 20 | 2 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 2.37e-03 | 163 | 20 | 2 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.37e-03 | 163 | 20 | 2 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.37e-03 | 163 | 20 | 2 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.43e-03 | 165 | 20 | 2 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.43e-03 | 165 | 20 | 2 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.43e-03 | 165 | 20 | 2 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 165 | 20 | 2 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-03 | 165 | 20 | 2 | 369d77a80d6401e85ea3121ab5a252f67d5f157e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.43e-03 | 165 | 20 | 2 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 2.43e-03 | 165 | 20 | 2 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.43e-03 | 165 | 20 | 2 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-03 | 166 | 20 | 2 | 76b4cd32698900797ec009f17e50ea7ae36b85f4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-03 | 166 | 20 | 2 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-03 | 166 | 20 | 2 | 30a991fc3275b571d53bd0976df4789e5d40b01d | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.49e-03 | 167 | 20 | 2 | 42b299273a6c72a625b204d55f4f3c4eebd6d185 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.49e-03 | 167 | 20 | 2 | 94642b3dae035fedb6e8b9745f440096a4539f3c | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 2.49e-03 | 167 | 20 | 2 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.49e-03 | 167 | 20 | 2 | ecf5bc634e1e01efd783617eb81d1704e903ea21 | |
| ToppCell | Tuft-tuft-1|World / Class top | 2.52e-03 | 168 | 20 | 2 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-03 | 168 | 20 | 2 | d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 168 | 20 | 2 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.52e-03 | 168 | 20 | 2 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-03 | 168 | 20 | 2 | bfa1491e8d433933003778b274710d3a16d973cb | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 2.52e-03 | 168 | 20 | 2 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-03 | 168 | 20 | 2 | f3164a85e5630ee8a745c6dba298e1f94ba4d5b8 | |
| Drug | alitame | 1.54e-05 | 7 | 20 | 2 | CID000064763 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.55e-05 | 177 | 20 | 4 | 6943_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 2.01e-05 | 189 | 20 | 4 | 1168_DN | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.23e-05 | 194 | 20 | 4 | 6779_DN | |
| Drug | Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.27e-05 | 195 | 20 | 4 | 3542_UP | |
| Drug | Carisoprodol [78-44-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 2.46e-05 | 199 | 20 | 4 | 1314_UP | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.51e-05 | 200 | 20 | 4 | 5284_DN | |
| Drug | DIEA | 1.24e-04 | 19 | 20 | 2 | CID000081531 | |
| Drug | oligomannose-8 | 2.17e-04 | 25 | 20 | 2 | CID015958586 | |
| Drug | PTC124 | 2.54e-04 | 27 | 20 | 2 | CID011219835 | |
| Drug | (2Z)-2-indol-3-ylidene-2-(2-sulfanylethoxyamino)acetic Acid | 2.73e-04 | 28 | 20 | 2 | CID011987734 | |
| Drug | cyclamate | 2.73e-04 | 28 | 20 | 2 | CID000007533 | |
| Drug | variolin B | 3.36e-04 | 31 | 20 | 2 | CID009817550 | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 4.17e-04 | 169 | 20 | 3 | 3464_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.78e-04 | 177 | 20 | 3 | 1069_DN | |
| Drug | 4-methylumbelliferyl-beta-D-glucopyranoside | 4.79e-04 | 37 | 20 | 2 | CID000087330 | |
| Drug | cyclopropavir | 4.79e-04 | 37 | 20 | 2 | CID003006048 | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 4.86e-04 | 178 | 20 | 3 | 5234_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 5.02e-04 | 180 | 20 | 3 | 1171_UP | |
| Drug | 17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A | 5.27e-04 | 183 | 20 | 3 | 1154_UP | |
| Drug | 15d-PGJ2; Up 200; 10uM; PC3; HT_HG-U133A | 5.27e-04 | 183 | 20 | 3 | 4455_UP | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 5.27e-04 | 183 | 20 | 3 | 4843_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 5.43e-04 | 185 | 20 | 3 | 4365_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 5.52e-04 | 186 | 20 | 3 | 4271_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 5.61e-04 | 187 | 20 | 3 | 3943_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.78e-04 | 189 | 20 | 3 | 5675_UP | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 5.87e-04 | 190 | 20 | 3 | 6177_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.96e-04 | 191 | 20 | 3 | 3905_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 5.96e-04 | 191 | 20 | 3 | 2627_UP | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 6.05e-04 | 192 | 20 | 3 | 6512_UP | |
| Drug | 5230742; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 6.05e-04 | 192 | 20 | 3 | 970_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 6.05e-04 | 192 | 20 | 3 | 458_DN | |
| Drug | 5279552; Up 200; 22uM; MCF7; HT_HG-U133A_EA | 6.05e-04 | 192 | 20 | 3 | 960_UP | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 6.15e-04 | 193 | 20 | 3 | 3446_UP | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 1307_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 1699_DN | |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 4105_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 3384_DN | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 4107_UP | |
| Drug | Enilconazole [35554-44-0]; Up 200; 13.4uM; PC3; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 5113_UP | |
| Drug | 5252917; Down 200; 14uM; MCF7; HT_HG-U133A_EA | 6.33e-04 | 195 | 20 | 3 | 944_DN | |
| Drug | leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA | 6.33e-04 | 195 | 20 | 3 | 1108_UP | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 2956_DN | |
| Drug | Ethacrynic acid [58-54-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 3181_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; HL60; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 3028_UP | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; HL60; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 3094_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 5360_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 1487_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.43e-04 | 196 | 20 | 3 | 1082_UP | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 7426_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; PC3; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 2073_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 2974_DN | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; HL60; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 1309_UP | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 6440_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; PC3; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 4620_UP | |
| Drug | Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 4408_UP | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 2749_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 6241_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 2782_UP | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 2695_DN | |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 4818_UP | |
| Drug | Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 7483_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; HL60; HG-U133A | 6.52e-04 | 197 | 20 | 3 | 1589_DN | |
| Drug | Bortezomib | 6.52e-04 | 838 | 20 | 5 | ctd:D000069286 | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 6476_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 6517_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 4414_UP | |
| Drug | Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; HL60; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 2959_DN | |
| Drug | HA-1077 dihydrochloride; Down 200; 10uM; PC3; HG-U133A | 6.62e-04 | 198 | 20 | 3 | 436_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; HL60; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 3033_UP | |
| Drug | Zoxazolamine [61-80-3]; Down 200; 23.8uM; PC3; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 6290_DN | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 1797_DN | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 6508_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; HL60; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 1841_UP | |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 3235_UP | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 3882_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 3193_UP | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 7023_UP | |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 5491_UP | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 4842_UP | |
| Drug | arachidonyl trifluoromethyl ketone; Up 200; 10uM; MCF7; HG-U133A | 6.62e-04 | 198 | 20 | 3 | 594_UP | |
| Drug | Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 6.72e-04 | 199 | 20 | 3 | 6249_DN | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 6.72e-04 | 199 | 20 | 3 | 3226_UP | |
| Drug | thioridazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 6.72e-04 | 199 | 20 | 3 | 422_DN | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.72e-04 | 199 | 20 | 3 | 1054_UP | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 6.72e-04 | 199 | 20 | 3 | 3164_UP | |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A | 6.72e-04 | 199 | 20 | 3 | 1633_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A | 6.72e-04 | 199 | 20 | 3 | 1933_DN | |
| Drug | iloprost; Down 200; 1uM; MCF7; HG-U133A | 6.72e-04 | 199 | 20 | 3 | 488_DN | |
| Drug | benserazide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 6.72e-04 | 199 | 20 | 3 | 641_UP | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 6.72e-04 | 199 | 20 | 3 | 6826_UP | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A | 6.82e-04 | 200 | 20 | 3 | 2175_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A | 6.82e-04 | 200 | 20 | 3 | 3078_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 6.82e-04 | 200 | 20 | 3 | 5512_DN | |
| Disease | diffuse plaque measurement | 9.52e-05 | 758 | 19 | 5 | EFO_0010699 | |
| Disease | age of onset of Alzheimer disease | 2.05e-04 | 33 | 19 | 2 | OBA_2001000 | |
| Disease | Congenital disorder of glycosylation | 2.72e-04 | 38 | 19 | 2 | cv:C0282577 | |
| Disease | biliary atresia | 5.93e-04 | 56 | 19 | 2 | MONDO_0008867 | |
| Disease | skin pigmentation | 8.98e-04 | 69 | 19 | 2 | EFO_0003784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MFHFFRKPPESKKPS | 1 | C9J7I0 | |
| PGRGSIPEFFHIMKR | 136 | Q9NRN7 | |
| KSLPGFSHMAPLPKF | 71 | Q13790 | |
| GHPSYAPPKRMRRKT | 561 | Q8WYB5 | |
| LMKRKFEEPRPGFHG | 276 | Q9NW15 | |
| PHVYFGMKTRSPKPL | 101 | Q13724 | |
| CKFPHKAMISSPPFR | 541 | Q9BXR6 | |
| MGFFKRAKHPEATVP | 1106 | Q13683 | |
| VKPRPGFHAMPSEIF | 341 | O15466 | |
| PKFKMPSFRVSAPGE | 2651 | Q8IVF2 | |
| LKAMRPHPGRPFFHT | 586 | Q9UPZ9 | |
| FFFPRAMPIGAKRAP | 276 | Q92959 | |
| RYKCPDMHRPFKVPL | 411 | Q9UPY5 | |
| FMHFPPKGRPKRADT | 151 | Q13454 | |
| PVEHPDKFLKFGMTP | 496 | P55072 | |
| RGGHKERPTVMLFPF | 276 | Q9BSI4 | |
| RMFQTKFKAHFPPRG | 341 | Q5VX71 | |
| KPEFMRRPDKHFDPF | 651 | Q9NQ66 | |
| DASGRLMPDPKRFPH | 86 | P17050 | |
| GGHSSPQRRMKPKEF | 91 | Q9ULJ8 |